Alcyone Therapeutics Announces First Patient Implanted in PIERRE IDE Clinical Study of the ThecaFlex DRx™ System for Administration of SPINRAZA® (nusinersen)

Alcyone's ThecaFlex DRx™ System is an FDA Breakthrough designated implantable medical device in clinical development to enable routine subcutaneous administration of therapeutics to the cerebrospinal fluid to potentially improve patient experience The first implantation of the ThecaFlex DRx™ System was performed at Texas Children's Hospital in Houston, Texas by PIERRE study investigator David Bauer, MD, MPH LOWELL, Mass., Jan. 3, 2024 /PRNewswire/ -- Alcyone Therapeutics Inc. (Alcyone), a biotechnology co ...